Stock Traders Purchase High Volume of Hyperliquid Strategies Call Options (NASDAQ:PURR)

Hyperliquid Strategies Inc (NASDAQ:PURR) was the recipient of unusually large options trading activity on Friday. Investors bought 39,870 call options on the stock. This represents an increase of approximately 28% compared to the average volume of 31,268 call options.

Institutional Trading of Hyperliquid Strategies

Hedge funds and other institutional investors have recently modified their holdings of the business. BlackRock Inc. bought a new stake in Hyperliquid Strategies in the 2nd quarter worth $79,842,000. Paradigm Operations LP purchased a new position in shares of Hyperliquid Strategies in the 4th quarter worth approximately $20,327,000. Galaxy Group Investments LLC bought a new position in Hyperliquid Strategies in the 4th quarter worth about $15,167,000. Pantera Capital Partners LP bought a new stake in Hyperliquid Strategies during the fourth quarter valued at about $14,545,000. Finally, Feynman Point Asset Management LLC purchased a new stake in Hyperliquid Strategies in the fourth quarter valued at approximately $14,431,000. Institutional investors own 9.45% of the company’s stock.

Hyperliquid Strategies Stock Down 4.6%

PURR traded down $0.58 during trading on Friday, hitting $12.19. The company’s stock had a trading volume of 16,106,758 shares, compared to its average volume of 10,422,011. The firm has a market capitalization of $1.76 billion, a P/E ratio of -1.90 and a beta of 1.89. Hyperliquid Strategies has a twelve month low of $3.01 and a twelve month high of $14.14. The stock’s fifty day moving average price is $8.15 and its 200-day moving average price is $7.10.

Wall Street Analysts Forecast Growth

PURR has been the topic of several recent analyst reports. Cantor Fitzgerald set a $22.60 target price on shares of Hyperliquid Strategies and gave the company an “overweight” rating in a research note on Thursday, August 27th. Weiss Ratings raised Hyperliquid Strategies from a “sell (d+)” rating to a “hold (c)” rating in a report on Friday, August 28th. Wall Street Zen downgraded Hyperliquid Strategies from a “hold” rating to a “sell” rating in a research note on Saturday, August 29th. Finally, Chardan Capital raised their price target on Hyperliquid Strategies from $9.75 to $17.00 and gave the stock a “buy” rating in a research report on Friday, August 28th. Three analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $16.53.

About Hyperliquid Strategies

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.